$4.90
+0.14 (+2.94%)
BOSC News2 articles
Boston Scientific Stock Rebounds on Positive Farapulse Data, CHAMPION-AF Trial Looms
Boston Scientific shares recovered slightly after a recent sell-off, supported by new long-term data for its Farapulse ablation system. Investor focus now shifts to the upcoming CHAMPION-AF trial results expected in late March.
Boston Scientific Shares Extend Decline Amid Electrophysiology Concerns
Boston Scientific stock fell 2.6% in Monday trading, continuing last week's selloff as investors scrutinize the company's heart-rhythm device segment and Watchman demand.